Lisata Therapeutics Inc (NASDAQ:LSTA), a clinical-stage pharmaceutical company focused on advanced solid tumors and serious diseases, announced that CEO Dr. David Mazzo will present a corporate overview at the 2025 BIO CEO & Investor Conference.
The event will take place on February 10-11, 2025, at the New York Marriott Marquis. Dr. Mazzo’s presentation is scheduled for February 10 at 2:00 p.m. ET.
More details and registration are available at bcic.bio.org/registration.